Home > Name List By 2 > 2-[2,3-dihydroxy-4-[3-hydroxy-5-(4-hydroxy-3, 5-dimethoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5, 5-dimethyl...

CAS No 56592-32-6 , 2-[2,3-dihydroxy-4-[3-hydroxy-5-(4-hydroxy-3,
5-dimethoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,
5-dimethyl-6-[(1E,3E)-penta-1,3-dienyl]oxan-2-yl]-N-[(2E,4E)-7-[3,
4-dihydroxy-5-[(1E,3E,5E,7E)-7-hydroxy-6-methyl-7-(1-methyl-2,
4-dioxopyridin-3-ylidene)hepta-1,3,
5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]butanamide

  • Name: 2-[2,3-dihydroxy-4-[3-hydroxy-5-(4-hydroxy-3,
    5-dimethoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,
    5-dimethyl-6-[(1E,3E)-penta-1,3-dienyl]oxan-2-yl]-N-[(2E,4E)-7-[3,
    4-dihydroxy-5-[(1E,3E,5E,7E)-7-hydroxy-6-methyl-7-(1-methyl-2,
    4-dioxopyridin-3-ylidene)hepta-1,3,
    5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]butanamide
  • Synonyms: Efrotomycine [French]; MK-621; Efrotomicina [Spanish];Producil; BRN 5230192; FR 02A;2-[2,3-dihydroxy-4-[3-hydroxy-5-(4-hydroxy-3,
    5-dimethoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,
    5-dimethyl-6-[(1E,3E)-penta-1,3-dienyl]oxan-2-yl]-N-[(2E,4E)-7-[3,
    4-dihydroxy-5-[(1E,3E,5E,7E)-7-hydroxy-6-methyl-7-(1-methyl-2,
    4-dioxopyridin-3-ylidene)hepta-1,3,
    5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]butanamide; 56592-32-6; Antibiotic FR 02A;
  • CAS Registry Number:
  • Refractive index: 1.574
  • Molecular Weight: 1145.33142
  • InchiKey: ZLECMEJICSWJLT-LIWMBINXSA-N
  • InChI: InChI=1S/C59H88N2O20/c1-15-17-19-27-39-58(8,
    9)53(80-56-45(67)50(74-13)49(35(7)76-56)79-57-51(75-14)44(66)48(73-12)34
    (6)77-57)52(68)59(71,
    81-39)36(16-2)54(69)60-29-23-22-25-32(4)46(72-11)33(5)47-43(65)42(64)38
    (78-47)26-21-18-20-24-31(3)41(63)40-37(62)28-30-61(10)55(40)70/h15,
    17-28,30,33-36,38-39,42-53,56-57,63-68,71H,16,29H2,1-14H3,(H,60,
    69)/b17-15+,20-18+,23-22+,26-21+,27-19+,31-24+,32-25+,41-40+
  • Molecular Formula: C59H88N2O20
  • Molecular Structure:CAS No:56592-32-6 2-[2,3-dihydroxy-4-[3-hydroxy-5-(4-hydroxy-3,<br />5-dimethoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,<br />5-dimethyl-6-[(1E,3E)-penta-1,3-dienyl]oxan-2-yl]-N-[(2E,4E)-7-[3,<br />4-dihydroxy-5-[(1E,3E,5E,7E)-7-hydroxy-6-methyl-7-(1-methyl-2,<br />4-dioxopyridin-3-ylidene)hepta-1,3,<br />5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]butanamide

Select to

56592-32-6 Efrotomycin

  • Efrotomycin, Min 99%
  • China Finechemie Co., Ltd. [Manufacturer]
  • Tel: +86-23-99186710
  • Fax: +86-23-99186729
  • Address: 28th Floor Mordern Building,New-Tech Zone400020 ChongqingCHINA Chongqing,nullChina
Contact Supplier

56592-32-6 EFROTOMYCIN

  • China Nanjing Chemlin Chemical Industry Co.,Ltd. [Manufacturer]
  • Tel: +86 25 8369-7070/ +86 138 51816776 (Mobile)
  • Fax: +86 25 8345-3275
  • Address: Rm.902 Longyin Plaza,
    No. 217 Zhongshan Rd.
    (N)Nanjing 210009,China null,nullChina
Contact Supplier

Select to

References of 2-[2,3-dihydroxy-4-[3-hydroxy-5-(4-hydroxy-3,
5-dimethoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,
5-dimethyl-6-[(1E,3E)-penta-1,3-dienyl]oxan-2-yl]-N-[(2E,4E)-7-[3,
4-dihydroxy-5-[(1E,3E,5E,7E)-7-hydroxy-6-methyl-7-(1-methyl-2,
4-dioxopyridin-3-ylidene)hepta-1,3,
5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]butanamide
Title: Efrotomycin
CAS Registry Number: 56592-32-6
CAS Name: 31-O-[6-Deoxy-4-O-(6-deoxy-2,4-di-O-methyl-a-L-mannopyranosyl)-3-O-methyl-b-D-allopyranosyl]-1-methylmocimycin
Synonyms: 31-O-[6-deoxy-4-O-(6-deoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin
Manufacturers' Codes: FR-02A; MK-621
Trademarks: Producil (Merck & Co.)
Molecular Formula: C59H88N2O20
Molecular Weight: 1145.33
Percent Composition: C 61.87%, H 7.74%, N 2.45%, O 27.94%
Literature References: Antibiotic produced by Streptomyces lactamdurans NRRL 3802: R. G. Wax, W. M. Maiese, DE 2450813 (1975 to Merck & Co.), C.A. 83, 145755y (1975); R. G. Wax et al., J. Antibiot. 29, 670 (1976). In vitro and in vivo activity: B. M. Frost et al., ibid. 1083; 32, 626 (1979). Production and growth promoting activity: W. M. Maiese, R. G. Wax, US 4024251 (1977 to Merck & Co.). Synergism with bottromycin, q.v.: B. M. Frost et al., J. Antibiot. 32, 1046 (1979). Structure: R. S. Dewey et al., ibid. 38, 1691 (1985). Stereospecific total synthesis: R. E. Dolle, K. C. Nicolaou, J. Am. Chem. Soc. 107, 1691, 1695 (1985). HPLC determn in feeds: J. D. Strong, Analyst 111, 853 (1986). Effect on gain and feed efficiency in swine: A. G. Foster et al., J. Anim. Sci. 65, 877 (1987).
Properties: Pale yellow solid. uv max (pH 7): 232, 327 nm (E1%1cm 464, 216). LD50 in mice (g/kg): >4 orally; >2 s.c. (Frost).
Absorption maximum: uv max (pH 7): 232, 327 nm (E1%1cm 464, 216)
Toxicity data: LD50 in mice (g/kg): >4 orally; >2 s.c. (Frost)
Therap-Cat-Vet: Growth stimulant.